Unknown

Dataset Information

0

No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.


ABSTRACT: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. A great majority of GISTs is driven by pathological activation of KIT or platelet-derived growth factor receptor-? (PDGFRA), two closely related receptor tyrosine kinases. However, other genetic changes including gain-of-function BRAF mutations and loss of succinate dehydrogenase (SDH) complex activity have been identified in the subsets of KIT-, PDGFRA-wild type tumors. Genetic mutations affecting KIT, PDGFRA, BRAF and SDH complex functions are believed to be mutually exclusive events. Recently, KRAS codon 12 and 13 mutations were reported in a small subset of KIT or PDGFRA mutant GISTs. Moreover, in in vitro experiments, KIT mutants with concurrent KRAS mutation showed resistance to imatinib, a receptor tyrosine kinase inhibitor used in GIST treatment. The aim of this study was to evaluate a large cohort of GISTs to define frequency and clinical significance of KRAS mutations in this type of cancer. A well-characterized cohort of 514 GISTs was screened for KRAS mutations using Sanger sequencing (n=450) and pyrosequencing (n=64). In all, 350 gastric, 100 intestinal and 64 primary disseminated GISTs were analyzed. No KRAS mutations were found. In GIST, KRAS mutations are extremely rare if they exist (<0.2%). Thus, mutational activation of KRAS does not seem to play any significant role in the development and progression of this type of cancer.

SUBMITTER: Lasota J 

PROVIDER: S-EPMC7560948 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases.

Lasota Jerzy J   Xi Liqiang L   Coates Tiffany T   Dennis RaShonda R   Evbuomwan Moses O MO   Wang Zeng-Feng ZF   Raffeld Mark M   Miettinen Markku M  

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20130524 11


Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. A great majority of GISTs is driven by pathological activation of KIT or platelet-derived growth factor receptor-α (PDGFRA), two closely related receptor tyrosine kinases. However, other genetic changes including gain-of-function BRAF mutations and loss of succinate dehydrogenase (SDH) complex activity have been identified in the subsets of KIT-, PDGFRA-wild type tumors. Genetic mutation  ...[more]

Similar Datasets

| S-EPMC4795049 | biostudies-literature
| S-EPMC5506287 | biostudies-literature
2006-01-10 | GSE4001 | GEO
| S-EPMC7825300 | biostudies-literature
| S-EPMC6509420 | biostudies-literature
| S-EPMC2819895 | biostudies-literature
2011-11-01 | GSE31802 | GEO
2011-11-01 | GSE31741 | GEO
2011-11-01 | E-GEOD-31741 | biostudies-arrayexpress
2011-11-01 | E-GEOD-31802 | biostudies-arrayexpress